INC Research has entered a definitive merger agreement to acquire Kendle International for approximately $232 million in cash. Kendle is a top global CRO with Phase I-IV clinical development expertise and more than 3,000 associates in 31 countries. Kendle’s board unanimously approved the transaction, which is expected to close in the third quarter, subject to customary closing conditions. Company founder Candace Kendle announced she was stepping down from her roles as president and chief executi...